Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

VCT tax relief cut to 20% for first time

3 min read
16:30UTC

The first reduction in VCT income tax relief since the scheme's creation in 1995 took effect on 6 April. The government says investors will migrate to EIS; the assumption is untested.

← Back to Stryker agrees option to buy CMR SurgicalJump to analysis ↓
TechnologyDeveloping
Key takeaway

The first VCT relief cut in 31 years reduces institutional early-stage capital with no proven replacement.

HM Treasury cut VCT income tax relief from 30% to 20% on 6 April 2026, the first reduction since Venture Capital Trusts were created in 1995⁠1. Simultaneously, the Enterprise Investment Scheme (EIS) lifetime company limit was doubled to £24m, and the annual company investment cap rose to £10m. The government projects the combined package unlocks approximately £100m of additional investment per year.

VCTs are the primary institutional vehicle for pooled early-stage investment. Angels use EIS (which retains 30% relief), but VCTs channel capital from retail investors into portfolios of small companies. The government argues investors will migrate from VCTs to EIS. That may hold for individual angel-backed rounds, but VCTs raised approximately £1bn in 2024-25. A 10 percentage point relief cut implies a contraction in new VCT fundraising that structurally smaller EIS angel rounds cannot fully offset.

The timing compounds the effect. Beauhurst data shows UK grant awards at their lowest count since 2016. VCT-funded early stages are the hardest to replace with alternative capital. For a pre-seed spinout needing £80,000 to prove a concept, the pipeline of institutional early-stage money just narrowed at the same moment the government is deploying billions at growth stage.

Deep Analysis

In plain English

A Venture Capital Trust (VCT) is a type of investment fund that pools money from ordinary savers and invests it in small, early-stage British companies. To encourage people to invest, the government gave a 30% tax break: invest £10,000, get £3,000 back from HMRC. From April 2026, that tax break dropped to 20%. This matters because VCTs are one of the main ways small British companies raise their first significant investment. If fewer people put money into VCTs (because the tax incentive is less attractive), fewer small companies can raise the early funding they need to get started. The government argues investors will switch to a similar scheme called EIS (Enterprise Investment Scheme), which still offers 30% relief. Critics say EIS and VCTs serve different functions and one cannot simply replace the other.

Deep Analysis
Root Causes

The VCT relief cut reflects a Treasury decision that the 30% rate, introduced in 1995 at a time when venture capital was a niche activity, now over-subsidises an asset class that has matured sufficiently to compete for retail capital on its own merits.

The structural tension is that VCTs serve a dual function: they provide early-stage company finance (a market-failure correction) and tax-efficient retirement savings vehicles for higher-rate taxpayers (a general saving incentive). The Treasury's cut implicitly judges that the savings function has become dominant and the investment subsidy rate should reflect that.

A secondary cause is Whitehall coordination failure. The VCT cut (Treasury decision) was made independently of the Innovate UK restructuring (DSIT decision) and the Sovereign AI Unit launch (also DSIT). No single department owns the seed-to-Series-A funding pipeline, so Treasury optimises for fiscal efficiency while DSIT deploys growth capital, and the two policies pull in opposite directions at different stages of the same companies.

What could happen next?
  • Consequence

    VCT fundraising may fall 25-35% in 2026-27 tax year, reducing seed-stage capital supply by £250-330m annually if the 2004 precedent holds.

    Short term · 0.65
  • Risk

    The combination of lower VCT fundraising and declining grant counts creates a structural gap in £250k-£2m funding at exactly the stage where most UK university spinouts need capital.

    Medium term · 0.7
  • Opportunity

    The EIS lifetime limit increase to £24m enables more capital per company from high-net-worth angels, which may partially compensate for VCT contraction in well-networked London-based startups.

    Short term · 0.6
Sources:HM Treasury / HMRC·HM Treasury / HMRC
Mentions:US Treasury →HMRC →Enterprise Investment Scheme →Institute for Fiscal Studies →Beauhurst →Venture Capital Trusts →Sovereign AI Unit →Innovate UK →HM Treasury →Octopus Ventures →
First Reported In

Update #1 · State capital floods in, seed money drains

HM Treasury / HMRC· 13 Apr 2026
Read original →
Causes and effects
This Event
VCT tax relief cut to 20% for first time
The cut weakens the primary institutional channel for pooled retail investment into early-stage UK companies.
Led to
VCTs hit £917.7m record, brace for 65% fall
The VCT fundraising record of £917.7m was a deadline rush directly caused by the November 2025 Budget announcement of the VCT relief cut (ID:2342), effective 6 April 2026.
Occurred 14 Apr 2026
Read story →
Ineffable lands $1.1bn seed, SAIU rides minority
VCT tax relief cut to 20% removed the retail seed pool; absence of VCT-backed angels from all rounds including Ineffable confirms the post-cut investor map.
Occurred 27 Apr 2026
Read story →
Paymentology raises $175m for card issuance expansion
The April 2026 VCT relief cut (ID:2342) creates seed-stage funding pressure, making the Paymentology $175m Series-stage raise representative of the resilience above seed that public capital does not reach.
Occurred 12 May 2026
Read story →
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.